Elevated A1C in Adults Without a History of Diabetes in the U.S

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2009 Feb 7

PMID 19196895

Citations 44

Authors

Elizabeth Selvin

Hong Zhu

Frederick L Brancati

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this study was to examine the prevalence and correlates of elevated A1C in a large, nationally representative sample of adults without diabetes in the U.S.

Research Design And Methods: We analyzed data from 15,934 participants aged >or=20 years without diagnosed diabetes who had A1C measurements in the 1999-2006 National Health and Nutrition Examination Survey, a cross-sectional and nationally representative sample of the U.S. population.

Results: The overall prevalence of A1C >6% was 3.8%, corresponding to 7.1 million adults without diabetes in the U.S. population. Approximately 90% of these individuals had fasting glucose >or=100 mg/dl. Older age, male sex, non-Hispanic black race/ethnicity, hypercholesterolemia, higher BMI, and lower attained education were significantly associated with having a higher A1C level even among individuals with normal fasting glucose (<100 mg/dl) and after multivariable adjustment.

Conclusions: A single elevated A1C level (A1C >6%) is common in the general population of adults without a history of diabetes and is highly reliable for the detection of elevated fasting glucose. Nondiabetic adults with elevated A1C are likely to have impaired fasting glucose and an array of other risk factors for type 2 diabetes and cardiovascular disease.

Citing Articles

Association between the atherogenic index of plasma and abdominal aortic calcification: results from the National Health and Nutrition Examination Survey 2013-2014.

Su X, Zhao C, Li D, Zhang X Front Endocrinol (Lausanne). 2025; 16:1472267.

PMID: 40034228 PMC: 11872722. DOI: 10.3389/fendo.2025.1472267.

Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use.

Sacks D, Kirkman M, Little R Diabetes Care. 2024; 47(7):1104-1110.

PMID: 38552140 PMC: 11208753. DOI: 10.2337/dci23-0040.

Factors Associated with Hemoglobin A1c Level Among Women Without Prior Diabetes Diagnosis in Rural Areas of Central South China: A Cross-Sectional Study.

Jiang Y, Jiang S, Long Q, Yang J, Chen J, Guo J Int J Womens Health. 2022; 14:741-755.

PMID: 35698488 PMC: 9188317. DOI: 10.2147/IJWH.S362143.

Vascular alterations impede fragile tolerance to pregnancy in type 1 diabetes.

McNew K, Abraham A, Sack D, Smart C, Pettway Y, Falk A F S Sci. 2022; 3(2):148-158.

PMID: 35560012 PMC: 9850286. DOI: 10.1016/j.xfss.2022.02.001.

Concordance between fasting plasma glucose and HbA in the diagnosis of diabetes in black South African adults: a cross-sectional study.

Wade A, Crowther N, Abrahams-Gessel S, Berkman L, George J, Gomez-Olive F BMJ Open. 2021; 11(6):e046060.

PMID: 34140342 PMC: 8212405. DOI: 10.1136/bmjopen-2020-046060.

References

Little R . Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med. 2003; 41(9):1191-8. DOI: 10.1515/CCLM.2003.183. View

Levitan E, Song Y, Ford E, Liu S . Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004; 164(19):2147-55. DOI: 10.1001/archinte.164.19.2147. View

Edelman D, Olsen M, Dudley T, Harris A, Oddone E . Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med. 2004; 19(12):1175-80. PMC: 1492588. DOI: 10.1111/j.1525-1497.2004.40178.x. View

Bennett C, Guo M, Dharmage S . HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 2007; 24(4):333-43. DOI: 10.1111/j.1464-5491.2007.02106.x. View

Levitan E, Liu S, Stampfer M, Cook N, Rexrode K, Ridker P . HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia. 2007; 51(2):267-75. PMC: 2757266. DOI: 10.1007/s00125-007-0882-y. View

Rohlfing C, LITTLE R, Wiedmeyer H, England J, Madsen R, Harris M . Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care. 2000; 23(2):187-91. DOI: 10.2337/diacare.23.2.187. View

Khaw K, Wareham N, Bingham S, Luben R, Welch A, Day N . Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004; 141(6):413-20. DOI: 10.7326/0003-4819-141-6-200409210-00006. View

LITTLE R, Rohlfing C, Wiedmeyer H, Myers G, Sacks D, Goldstein D . The national glycohemoglobin standardization program: a five-year progress report. Clin Chem. 2001; 47(11):1985-92. View

Ko G, Chan J, Tsang L, Cockram C . Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care. 2000; 23(12):1770-3. DOI: 10.2337/diacare.23.12.1770. View

10.

Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles M . Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2006; 29(7):1619-25. DOI: 10.2337/dc05-2525. View

11.

Inoue K, Matsumoto M, Kobayashi Y . The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract. 2007; 77(3):451-8. DOI: 10.1016/j.diabres.2007.01.024. View

12.

Davidson M, Schriger D, Peters A, Lorber B . Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999; 281(13):1203-10. DOI: 10.1001/jama.281.13.1203. View

13.

Buell C, Kermah D, Davidson M . Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007; 30(9):2233-5. DOI: 10.2337/dc07-0585. View

14.

Selvin E, Crainiceanu C, Brancati F, Coresh J . Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med. 2007; 167(14):1545-51. DOI: 10.1001/archinte.167.14.1545. View

15.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31 Suppl 1:S55-60. DOI: 10.2337/dc08-S055. View

16.

Selvin E, Coresh J, Golden S, Brancati F, Folsom A, Steffes M . Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med. 2005; 165(16):1910-6. DOI: 10.1001/archinte.165.16.1910. View

17.

Rohlfing C, Wiedmeyer H, Little R, Grotz V, Tennill A, England J . Biological variation of glycohemoglobin. Clin Chem. 2002; 48(7):1116-8. View

18.

Saudek C, Herman W, Sacks D, Bergenstal R, Edelman D, Davidson M . A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008; 93(7):2447-53. DOI: 10.1210/jc.2007-2174. View

19.

Pradhan A, Rifai N, Buring J, Ridker P . Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med. 2007; 120(8):720-7. PMC: 2585540. DOI: 10.1016/j.amjmed.2007.03.022. View

20.

Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett A . Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol. 2005; 4(12):821-6. DOI: 10.1016/S1474-4422(05)70227-1. View